Medicare Enrolled

Dr. Amadou Camara, MD

Epilepsy Physician · Durham, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2301 ERWIN RD, Durham, NC 27705
9196848111
Registered in NPPES since 2018
NPI: 1083102453 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Camara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Camara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Camara

Dr. Amadou Camara is an epilepsy physician in Durham, NC, with 8 years of NPI registration. Based on federal Medicare data, Dr. Camara performed 316 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Camara received a total of $13,257 from 49 pharmaceutical and/or device companies across 234 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Camara is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years of NPI registration ▲ Top 50% volume in NC $13,257 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
316
Medicare services
Top 50% in NC for epilepsy physician
Not available
Unique patients (not deduplicated)
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
84 $114 $395
New patient office visit, complex (60-74 min) 77 $152 $495
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
52 $122 $350
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $79 $260
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
41 $262 $1,199
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $312 $1,425
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,257
Total received (2021-2024)
Avg $3,314/year across 4 years
Top 25% in NC for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
234
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,485
2023
$2,397
2022
$279
2021
$96

Payments by company (2024)

LivaNova USA, Inc.
$7,728
UCB, Inc.
$687
ABBVIE INC.
$230
Neurelis, Inc.
$194
Biogen, Inc.
$159
JAZZ PHARMACEUTICALS INC.
$158
Alexion Pharmaceuticals, Inc.
$126
Lundbeck LLC
$116
SK Life Science, Inc.
$110
Mallinckrodt Hospital Products Inc.
$86
PFIZER INC.
$85
TG Therapeutics, Inc.
$69
CSL Behring
$68
EMD Serono, Inc.
$63
Eisai Inc.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$52
ARGENX US, INC.
$50
Lilly USA, LLC
$46
Avadel CNS Pharmaceuticals, LLC
$38
Acorda Therapeutics, Inc
$35
Merz Pharmaceuticals, LLC
$31
ACADIA Pharmaceuticals Inc
$28
Vanda Pharmaceuticals Inc.
$28
Novo Nordisk Inc
$28
Ultragenyx Pharmaceutical Inc.
$28
BANNER LIFE SCIENCES, LLC
$28
HARMONY BIOSCIENCES LLC
$27
Genentech USA, Inc.
$21
Amneal Pharmaceuticals LLC
$21
SCILEX PHARMACEUTICALS INC.
$19
Axsome Therapeutics, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2021-2024) ›
LivaNova USA, Inc.
$8,111
UCB, Inc.
$971
Biogen, Inc.
$291
PFIZER INC.
$251
Lundbeck LLC
$244
Alexion Pharmaceuticals, Inc.
$243
JAZZ PHARMACEUTICALS INC.
$238
ABBVIE INC.
$230
Otsuka America Pharmaceutical, Inc.
$221
Neurelis, Inc.
$211
SK Life Science, Inc.
$184
ARGENX US, INC.
$166
Merz Pharmaceuticals, LLC
$144
EMD Serono, Inc.
$113
Otsuka Pharmaceutical Development & Commercialization, Inc.
$112
CSL Behring
$109
Mallinckrodt Hospital Products Inc.
$107
Sunovion Pharmaceuticals Inc.
$96
Eisai Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$80
Acorda Therapeutics, Inc
$79
TG Therapeutics, Inc.
$69
Axsome Therapeutics, Inc.
$68
AbbVie Inc.
$67
Lilly USA, LLC
$64
ACADIA Pharmaceuticals Inc
$59
Teva Pharmaceuticals USA, Inc.
$56
Amgen Inc.
$55
Amneal Pharmaceuticals LLC
$54
TG THERAPEUTICS, INC.
$46
Avadel CNS Pharmaceuticals, LLC
$38
Corium, LLC
$33
IMPEL PHARMACEUTICALS INC.
$31
Vanda Pharmaceuticals Inc.
$28
Novo Nordisk Inc
$28
Ultragenyx Pharmaceutical Inc.
$28
BANNER LIFE SCIENCES, LLC
$28
HARMONY BIOSCIENCES LLC
$27
Microtransponder, Inc.
$21
Genentech USA, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$19
Medtronic, Inc.
$19
Celgene Corporation
$18
Avion Pharmaceuticals
$17
Sandoz Inc.
$17
Collegium Pharmaceutical, Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
GENZYME CORPORATION
$15
Neurocrine Biosciences, Inc.
$13
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · DUOPA · Dhivy · Dojolvi · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Fintepla · HYQVIA · Hizentra · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · LUMRYZ · Leqembi · MAVENCLAD · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · PANZYGA · PONVORY · QULIPTA · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · Skyclarys · Sunosi · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · Wegovy · XYWAV · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an epilepsy physician in Durham?
Compare epilepsy physicians in the Durham area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians in nearby ZIP areas
1
County median income
$79,501
Nearest hospital to ZIP centroid (approximate)
DUKE UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Camara is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Camara experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Camara performed 84 new patient office visit (45-59 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Camara receive payments from pharmaceutical companies?
Yes. Dr. Camara received a total of $13,257 from 49 companies across 234 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Camara's costs compare to other epilepsy physicians in Durham?
Dr. Camara's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Camara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →